Summary of time trends in age-standardised lymphoma incidence, survival and mortality in Manitoba, Canada
| Lymphoma classification | Sex | Incidence | Survival | Mortality |
| Total HL | Male | ̶ | ↑ | ↓ |
| Female | ̶ | NT | ↓ | |
| Total NHL | Male | ↑, before 1998; ̶ , after 1998 | ↑ | ↑, before 1999; ↓, after 1999 |
| Female | ↑, before 2001; ̶ , after 2001 | ↑ | ↑, before 1998; ↓, after 1998 | |
| CLL/SLL | Male | ↑, before 2010; ̶ , after 2010 | ↑ | NT |
| Female | ↑, before 2010; ↓, after 2010 | ↑ | NT | |
| DLBCL | Male | ↑ | ↑ | NT |
| Female | ↑ | ↑ | NT | |
| FL | Male | ↑, before 2003; ̶ , after 2003 | ↑ | NT |
| Female | ↑ | ̶ | NT | |
| PCN | Male | ↑ | ↑ | NT |
| Female | ̶ | ̶ | NT |
— denotes no change.
CLL/SLL, chronic/small lymphocytic leukaemia/lymphoma; DLBCL, diffuse large B cell lymphoma; FL, follicular lymphoma; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; NT, not tested; PCN, plasma cell neoplasm.